ACE and congestive heart failure: Using data from the multinational observational BIOSTAT-CHF study, Nauta et al. demonstrated that HFrEF patients with eccentric hypertrophy may have greater a greater mortality benefit from uptitration of angiotensin-converting enzyme inhibitors / angiotensin receptor blockers and beta-blockers compared to HFrEF patients with concentric hypertrophy [22].